Full-Time
AI Engineer
Confirmed live in the last 24 hours
Chai Discovery
Develops AI models for molecular predictions
Mid
San Francisco, CA, USA
Position is based full-time in San Francisco, CA.
- Bachelor’s or Master’s degree in Computer Science, Software Engineering, or a related field.
- Strong proficiency in programming languages such as Python.
- Deep understanding of operating system internals (Unix).
- Experience with high-performance computing (HPC) infrastructure such as Slurm and Kubernetes.
- Experience with performance engineering (familiarity with profiling tools, optimizing CPU and GPU workloads, writing CUDA and Triton kernels, and so forth)
- Experience writing, building, and maintaining large-scale ETL pipelines.
- Experience using deep learning libraries such as PyTorch.
- Collaborate with AI researchers to design, implement, and maintain software systems that support AI-driven drug discovery applications.
- Develop and optimize high-performance computing (HPC) infrastructure.
- Integrate AI models into production systems, platforms, and front-end applications, ensuring scalability and reliability.
Chai Discovery develops AI foundation models that focus on predicting and reprogramming interactions between biochemical molecules, which are crucial for life. Their main product, Chai 1, is a multimodal model that can predict various molecular structures such as proteins, small molecules, DNA, RNA, and covalent modifications. This model is available for free through a web interface, making it accessible for both academic researchers and pharmaceutical companies involved in drug discovery. Unlike many competitors, Chai Discovery emphasizes a user-friendly platform that allows clients to easily integrate AI into their research and development processes. The company's goal is to enhance the efficiency of molecular research and drug discovery through advanced AI technology.
Company Stage
Seed
Total Funding
$29.2M
Headquarters
null, California
Founded
N/A
Simplify's Take
What believers are saying
- The recent $30 million investment from prominent backers like Thrive Capital and OpenAI indicates strong confidence in Chai Discovery's potential and growth trajectory.
- Chai Discovery's AI-driven platform can significantly accelerate drug discovery processes, offering substantial value to pharmaceutical companies and researchers.
- The company's innovative approach to molecular research could lead to groundbreaking discoveries in drug development and other biotechnological applications.
What critics are saying
- The rapid growth and high expectations from investors could pressure Chai Discovery to deliver results quickly, potentially leading to strategic missteps.
- The competitive landscape in AI-driven drug discovery is intensifying, with numerous startups and established companies vying for market share.
What makes Chai Discovery unique
- Chai Discovery's focus on AI foundation models for predicting and reprogramming biochemical interactions sets it apart from traditional biotech firms that may not leverage AI to the same extent.
- The free accessibility of Chai 1 for both academic and commercial use democratizes advanced molecular research tools, unlike competitors who may restrict access through high costs.
- Their specialization in a wide range of molecular structures, including proteins, DNA, and RNA, provides a comprehensive platform that is rare in the biotech industry.
Help us improve and share your feedback! Did you find this helpful?